Ongoing clinical trials

We’re dedicated to breaking boundaries through clinical studies and to finding new and improved ways to treat cancer that deliver better life outcomes for our patients

Ongoing clinical trials 22 clinical trials

Cancer

MAVIS Melanoma

A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients With a High Risk of Recurrence

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

MROQC

MROQC

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

CTP-2

Intensity Modulated Radiation Therapy followed by Cesium‐131 Brachytherapy for Intermediate and High Risk Localized Prostate Cancer.

Ongoing 2020 Florida West Coast

Cancer

GU005

PHASE III IGRT AND SBRT VS IGRT AND HYPOFRACTIONATED IMRT FOR LOCALIZED INTERMEDIATE RISK PROSTATE CANCER

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

GU003

A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

Astellas 2215-CL-0302

A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation

Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217

Cancer

BMS CA209-234

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

UTX-TGR-205

Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 and TGR-1202 Alone in Patients With Previously Treated Diffuse Large B-Cell Lymphoma (UNITY-DLBCL)

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

TG Therapeutics 304

A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic

Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217

Cancer

PCYC-1134M

A Disease Registry for Patients with Chronic Lymphocytic Leukemia

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

B-51

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Ch

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

S1806

SWOG/NRG Joint Study: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

S1914

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

LU005

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

CC003

A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

UTX-TGR-205-2b

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgk

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

DCISionRT

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy

Ongoing 2020 Florida East Coast: Peggy Mouradian (954) 370-7555 and Florida West Coast-Fort Myers: Lauren Embry (239) 344-2232

Cancer

BGB-3111-215

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrut

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

Cancer

EA5181

Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

BMS CA209-651

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Study Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of t

Ongoing 2020 North Florida / Jacksonville: Astrid Corrales-Cruz (904) 427-1217

Cancer

Novocure METIS EF-25

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

Ongoing 2020 Michigan: Maria Pappas (248) 553-0606

Cancer

OBS16577

A prospective, non-interventional, multinational, observational study with isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM)

Ongoing 2020 North Florida / Jacksonville: Rhonda Calhoun (904) 427-1217

No Results